Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years
- PMID: 2344206
- PMCID: PMC1004068
- DOI: 10.1136/ard.49.5.283
Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years
Abstract
Still's disease is a clinical entity of unknown origin, which can appear before 15 years of age (juvenile onset Still's disease) or later (adult onset Still's disease). There are few reported data about the long term prognosis of Still's disease and no study compares the long term evolution of adult onset and juvenile onset Still's disease. Eighteen patients fulfilling the American Rheumatism Association criteria for Still's disease were followed up for more than 10 years. Ten (group 1) had juvenile onset Still's disease and eight (group 2) adult onset Still's disease. A comparison of the groups showed no significant differences in the initial systemic manifestations of Still's disease, or in the joint lesions. Both groups had severe sequelae, which appeared between six and 10 years after the initial flare up of Still's disease. Nine patients had articular damage and nine had only arthritis without apparent x ray abnormalities. Nine patients had bilateral hip destruction in less than four years. Of these nine, seven required 13 total hip replacements before the age of 45. In the whole group of 18 patients bilateral involvement of the following joints was also seen: carpus (seven patients), knee (four), tarsus (four), ankle (three); three patients had ankylosis of the cervical spine. The occurrence of amyloidosis (three cases, two deaths) was restricted to group 2. This was the only difference between the groups, as the treatments were identical. It is concluded that the articular prognosis of Still's disease is poor, be it adult onset or juvenile onset, with severe joint destruction in half of the patients.
Similar articles
-
"Adolescent-onset Still's disease": characteristics and outcome in comparison with adult-onset Still's disease.Clin Exp Rheumatol. 2002 May-Jun;20(3):427-30. Clin Exp Rheumatol. 2002. PMID: 12102485
-
Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease.Arthritis Rheum. 1982 Jun;25(6):647-54. doi: 10.1002/art.1780250607. Arthritis Rheum. 1982. PMID: 7092964
-
Still's disease in an adult: A link between juvenile and adult rheumatoid arthritis.Am J Med Sci. 1975 Jan-Feb;269(1):137-44. doi: 10.1097/00000441-197501000-00015. Am J Med Sci. 1975. PMID: 1130432
-
[Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].Z Rheumatol. 2020 Sep;79(7):639-648. doi: 10.1007/s00393-020-00779-2. Z Rheumatol. 2020. PMID: 32253510 Review. German.
-
[Systemic chronic juvenile arthritis (Still's disease) in adults. Review of the literature].Schweiz Med Wochenschr. 1983 Jan 29;113(4):126-37. Schweiz Med Wochenschr. 1983. PMID: 6338586 Review. German.
Cited by
-
Prognostic factors in juvenile idiopathic arthritis.Curr Rheumatol Rep. 2001 Oct;3(5):371-8. doi: 10.1007/s11926-996-0006-6. Curr Rheumatol Rep. 2001. PMID: 11564367 Review.
-
Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity.BMC Rheumatol. 2019 Feb 28;3:4. doi: 10.1186/s41927-019-0053-z. eCollection 2019. BMC Rheumatol. 2019. PMID: 30886992 Free PMC article.
-
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome.J Clin Invest. 2023 Nov 15;133(22):e165616. doi: 10.1172/JCI165616. J Clin Invest. 2023. PMID: 37751296 Free PMC article.
-
Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline.Z Rheumatol. 2023 Feb;82(Suppl 2):81-92. doi: 10.1007/s00393-022-01294-2. Epub 2022 Dec 15. Z Rheumatol. 2023. PMID: 36520170 Review. English. No abstract available.
-
Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.Arthritis Res Ther. 2022 Apr 29;24(1):92. doi: 10.1186/s13075-022-02780-3. Arthritis Res Ther. 2022. PMID: 35488289 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical